Skip to main content
SpringerLink
Log in

Mitochondrial involvement in myocyte death and heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

As the heart is an energy-demanding organ, impaired cardiac energy metabolism and mitochondrial function have been inexorably linked to cardiac dysfunction. There is a growing recognition that mitochondrial dysfunction contributes to impaired myocardial energetics and increased oxidative stress in cardiomyopathies, cardiac ischemic damage and heart failure (HF), and mitochondrial permeability transition pore opening has been reported a critical trigger of myocyte death and myocardial remodeling. It is well established that mitochondria play pivotal roles in intracellular signaling in both cell death as well as in cardioprotective pathways. Moreover, recent studies have shown that defects in mitochondrial dynamics affecting biogenesis and turnover are linked to cardiac senescence and HF. Accordingly, there has been an increasing interest in targeting mitochondria for HF therapy. This article reviews the background and recent evidence of mitochondrial involvement in several types of cell death (apoptosis, necrosis and autophagy) occurring in HF. In addition, potential strategies for targeting mitochondria are examined, and their utility in HF therapy considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Leri A, Kajstura J, Anversa P (2011) Mechanisms of myocardial regeneration. Trends Cardiovasc Med 21:52–58

    Article  PubMed Central  PubMed  Google Scholar 

  2. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497–1504

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Nakayama H, Chen X, Baines CP, Klevitsky R, Zhang X, Zhang H, Jaleel N, Chua BH, Hewett TE, Robbins J, Houser SR, Molkentin JD (2007) Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 117:2431–2444

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Mughal W, Dhingra R, Kirshenbaum LA (2012) Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep 14:540–547

    Article  CAS  PubMed  Google Scholar 

  5. Gottlieb RA, Mentzer RM Jr (2013) Autophagy: an affair of the heart. Heart Fail Rev 18:575–584

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Green DR, Galluzzi L, Kroemer G (2014) Cell biology. Metabolic control of cell death. Science 345:1250256

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Konstantinidis K, Whelan RS, Kitsis RN (2012) Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 32:1552–1562

    Article  CAS  PubMed  Google Scholar 

  8. Karch J, Kwong JQ, Burr AR, Sargent MA, Elrod JW, Peixoto PM, Martinez-Caballero S, Osinska H, Cheng EH, Robbins J, Kinnally KW, Molkentin JD (2013) Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. Elife 2:e00772

    Article  PubMed Central  PubMed  Google Scholar 

  9. Andres AM, Stotland A, Queliconi BB, Gottlieb RA (2015) A time to reap, a time to sow: mitophagy and biogenesis in cardiac pathophysiology. J Mol Cell Cardiol 78:62–72

    Article  CAS  PubMed  Google Scholar 

  10. Orogo AM, Gustafsson ÅB (2013) Cell death in the myocardium: my heart won’t go on. IUBMB Life 65:651–656

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305–1308

    Article  CAS  PubMed  Google Scholar 

  12. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288:2354–2357

    Article  CAS  PubMed  Google Scholar 

  13. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795–7798

    Article  CAS  PubMed  Google Scholar 

  14. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–5588

    PubMed Central  CAS  PubMed  Google Scholar 

  15. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803–815

    Article  CAS  PubMed  Google Scholar 

  16. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273:2926–2930

    Article  CAS  PubMed  Google Scholar 

  17. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, Green DR, Reed JC, Froelich CJ, Salvesen GS (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273:27084–27090

    Article  CAS  PubMed  Google Scholar 

  18. Kushnareva Y, Newmeyer DD (2010) Bioenergetics and cell death. Ann NY Acad Sci 1201:50–57

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95–99

    Article  CAS  PubMed  Google Scholar 

  20. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441–446

    Article  CAS  PubMed  Google Scholar 

  21. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW (2002) Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9:423–432

    Article  CAS  PubMed  Google Scholar 

  22. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157

    Article  CAS  PubMed  Google Scholar 

  23. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205–219

    Article  CAS  PubMed  Google Scholar 

  24. Tait SW, Green DR (2013) Mitochondrial regulation of cell death. Cold Spring Harb Perspect Biol. 5 pii: a008706

  25. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Changs BS, Thompson CB, Wong S, Ng S, Fesik SW (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (London) 381:335–341

    Article  CAS  Google Scholar 

  26. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, Martinou JC (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370–372

    Article  CAS  PubMed  Google Scholar 

  27. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou J (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345:271–278

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Chipuk JE, Green DR (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18:157–164

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Kushnareva Y, Andreyev AY, Kuwana T, Newmeyer DD (2012) Bax activation initiates the assembly of a multimeric catalyst that facilitates Bax pore formation in mitochondrial outer membranes. PLoS Biol 10:e1001394

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Basañez G, Soane L, Hardwick JM (2012) A new view of the lethal apoptotic pore. PLoS Biol 10:e1001399

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  31. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727–730

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Raemy E, Martinou JC (2014) Involvement of cardiolipin in tBID-induced activation of BAX during apoptosis. Chem Phys Lipids 179:70–74

    Article  CAS  PubMed  Google Scholar 

  33. Danial NN (2008) BAD: undertaker by night, candyman by day. Oncogene 27(Suppl 1):S53–S70

    Article  CAS  PubMed  Google Scholar 

  34. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010–1014

    Article  CAS  PubMed  Google Scholar 

  35. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR (2000) The coordinate release of cytochrome during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2:156–162

    Article  CAS  PubMed  Google Scholar 

  36. Lartigue L, Medina C, Schembri L, Chabert P, Zanese M, Tomasello F, Dalibart R, Thoraval D, Crouzet M, Ichas F, De Giorgi F (2008) An intracellular wave of cytochrome c propagates and precedes Bax redistribution during apoptosis. J Cell Sci 121:3515–3523

    Article  CAS  PubMed  Google Scholar 

  37. Bhola PD, Mattheyses AL, Simon SM (2009) Spatial and temporal dynamics of mitochondrial membrane permeability waves during apoptosis. Biophys J 97:2222–2231

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, Anversa P (1999) Myocyte death in the failing human heart is gender dependent. Circ Res 85:856–866

    Article  CAS  PubMed  Google Scholar 

  39. Henriquez M, Armisen R, Stutzin A, Quest AF (2008) Cell death by necrosis, a regulated way to go. Curr Mol Med 8:187–206

    Article  CAS  PubMed  Google Scholar 

  40. Savage MK, Reed DJ (1994) Oxidation of pyridine nucleotides and depletion of ATP and ADP during calcium- and inorganic phosphate-induced mitochondrial permeability transition. Biochem Biophys Res Commun 200:1615–1620

    Article  CAS  PubMed  Google Scholar 

  41. Crompton M, Costi A (1990) A heart mitochondrial Ca2(+)-dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states. Biochem J 266:33–39

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Vercesi AE, Kowaltowski AJ, Grijalba MT, Meinicke AR, Castilho RF (1997) The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep 7:43–52

    Article  Google Scholar 

  43. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366:177–196

    Article  CAS  PubMed  Google Scholar 

  44. Kottke M, Adam V, Riesinger I, Bremm G, Bosch W, Brdiczka D, Sandri G, Panfili E (1988) Mitochondrial boundary membrane contact sites in brain: points of hexokinase and creatine kinase location, and control of Ca2+ transport. Biochim Biophys Acta 935:87–102

    Article  CAS  PubMed  Google Scholar 

  45. Di Lisa F, Bernardi P (1998) Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem 184:379–391

    Article  PubMed  Google Scholar 

  46. Broekemeier KM, Iben JR, LeVan EG, Crouser ED, Pfeiffer DR (2002) Pore formation and uncoupling initiate a Ca2+-independent degradation of mitochondrial phospholipids. Biochemistry 41:7771–7780

    Article  CAS  PubMed  Google Scholar 

  47. Pepe S (2000) Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol Physiol 27:745–750

    Article  CAS  PubMed  Google Scholar 

  48. Haworth RA, Hunter DR (1979) The Ca2+ induced membrane transition in mitochondria. II. Nature of the Ca 2þ trigger site. Arch Biochem Biophys 195:460–467

    Article  CAS  PubMed  Google Scholar 

  49. Crompton M, Costi A (1988) Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+-overload. Eur J Biochem 178:489–501

    Article  CAS  PubMed  Google Scholar 

  50. Griffiths EJ, Halestrap AP (1991) Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis–trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. Biochem J 274:611–614

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Connern CP, Halestrap AP (1994) Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem J 302:321–324

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Griffiths EJ, Halestrap AP (1995) Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307:93–98

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Hunter DR, Haworth RA (1979) The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch Biochem Biophys 195:468–477

    Article  CAS  PubMed  Google Scholar 

  54. Halestrap AP (1990) Davidson AM (1990) Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis–trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268:153–160

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Brustovetsky N, Becker A, Klingenberg M, Bamberg E (1996) Electrical currents associated with nucleotide transport by the reconstituted mitochondrial ADP/ATP carrier. Proc Natl Acad Sci USA 93:664–668

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Leung AW, Halestrap AP (2008) Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 1777:946–995

    Article  CAS  PubMed  Google Scholar 

  57. Chen C, Ko Y, Delannoy M, Ludtke SJ, Chiu W, Pedersen PL (2004) Mitochondrial ATP synthasome: three-dimensional structure by electron microscopy of the ATP synthase in complex formation with carriers for pi and ADP/ATP. J Biol Chem 279:31761–33176

    Article  CAS  PubMed  Google Scholar 

  58. Szabo I, Zoratti M (1993) The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett 330:201–205

    Article  CAS  PubMed  Google Scholar 

  59. Szabo I, De Pinto V, Zoratti M (1993) The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 330:206–210

    Article  CAS  PubMed  Google Scholar 

  60. Pasdois P, Parker JE, Griffiths EJ, Halestrap AP (2013) Hexokinase II and reperfusion injury: TAT-HK2 peptide impairs vascular function in Langendorff-perfused rat hearts. Circ Res 112:e3–e7

    Article  CAS  PubMed  Google Scholar 

  61. Beutner G, Ruck A, Riede B, Brdiczka D (1998) Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1368:7–18

    Article  CAS  PubMed  Google Scholar 

  62. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, Wallace DC (2004) The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427:461–465

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD (2007) Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9:550–555

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Krauskopf A, Eriksson O, Craigen WJ, Forte MA, Bernardi P (2006) Properties of the permeability transition in VDAC1−/− mitochondria. Biochim Biophys Acta 1757:590–595

    Article  CAS  PubMed  Google Scholar 

  65. Sileikyte J, Blachly-Dyson E, Sewell R, Carpi A, Menabo R, Di Lisa F, Ricchelli F, Bernardi P, Forte M (2014) Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (TSPO). J Biol Chem 289:13769–13781

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. Herick K, Krämer R, Lühring H (1997) Patch clamp investigation into the phosphate carrier from Saccharomyces cerevisiae mitochondria. Biochim Biophys Acta 1321:207–220

    Article  CAS  PubMed  Google Scholar 

  67. Kwong JQ, Davis J, Baines CP, Sargent MA, Karch J, Wang X (2014) Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 21:1209–1217

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Gutiérrez-Aguilar M, Douglas DL, Gibson AK, Domeier TL, Molkentin JD, Baines CP (2014) Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition. J Mol Cell Cardiol 72:316–325

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  69. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658–662

    Article  CAS  PubMed  Google Scholar 

  70. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P (2005) Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 280:18558–18561

    Article  CAS  PubMed  Google Scholar 

  71. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, Hetz C, Danial NN, Moskowitz MA, Korsmeyer SJ (2005) Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 102:12005–12010

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, Bernardi P (2010) Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci USA 107:726–731

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  73. Nguyen TT, Stevens MV, Kohr M, Steenbergen C, Sack MN, Murphy E (2011) Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 286:40184–40189

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Eliseev RA, Malecki J, Lester T, Zhang Y, Humphrey J, Gunter TE (2009) Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 284:9692–9699

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  75. Giorgio V, Bisetto E, Soriano ME, Dabbeni-Sala F, Basso E, Petronilli V, Forte MA, Bernardi P, Lippe G (2009) Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 284:33982–33988

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  76. Antoniel M, Giorgio V, Fogolari F, Glick GD, Bernardi P, Lippe G (2014) The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology. Int J Mol Sci 15:7513–7536

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  77. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, Glick GD, Petronilli V, Zoratti M, Szabó I, Lippe G, Bernardi P (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 110:5887–5892

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  78. Bonora M, Bononi A, DeMarchi E, Giorgi C, Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM, Wojtala A, Wieckowski MR, Kroemer G, Galluzzi L, Pinton P (2013) Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12:674–683

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  79. Alavian KN, Beutner G, Lazrove E, Sacchetti S, Park HA, Licznerski P, Li H, Nabili P, Hockensmith K, Graham M, Porter GA Jr, Jonas EA (2014) An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci USA 111:10580–10585

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  80. Carraro M, Giorgio V, Šileikytė J, Sartori G, Forte M, Lippe G, Zoratti M, Szabò I, Bernardi P (2014) Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J Biol Chem 289:15980–15985

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  81. Azarashvili TS, Tyynelä J, Odinokova IV, Grigorjev PA, Baumann M, Evtodienko YV, Saris NE (2002) Phosphorylation of a peptide related to subunit c of the F0F1-ATPase/ATP synthase and relationship to permeability transition pore opening in mitochondria. J Bioenerg Biomembr 34:279–284

    Article  CAS  PubMed  Google Scholar 

  82. Jonas EA, Porter GA Jr, Beutner G, Mnatsakanyan N, Alavian KN (2015) Cell death disguised: the mitochondrial permeability transition pore as the c-subunit of the F(1)F(O) ATP synthase. Pharmacol Res 99:382–392

    Article  CAS  PubMed  Google Scholar 

  83. Bonora M, Wieckowski MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P (2015) Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 34:1475–1486

    Article  CAS  PubMed  Google Scholar 

  84. Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46:821–831

    Article  CAS  PubMed  Google Scholar 

  85. Halestrap AP (2014) The C ring of the F1Fo ATP synthase forms the mitochondrial permeability transition pore: a critical appraisal. Front Oncol 4:234

    Article  PubMed Central  PubMed  Google Scholar 

  86. Bernardi P, Di Lisa F, Fogolari F, Lippe G (2015) From ATP to PTP and back: a dual function for the mitochondrial ATP synthase. Circ Res 116:1850–1862

    Article  CAS  PubMed  Google Scholar 

  87. Bernardi P (2013) The mitochondrial permeability transition pore: a mystery solved? Front Physiol 4:95

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  88. Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, Di Lisa F, Forte MA (2006) The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273:2077–2099

    Article  CAS  PubMed  Google Scholar 

  89. Fontaine E, Eriksson O, Ichas F, Bernardi P (1998) Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I. J Biol Chem 273:12662–12668

    Article  CAS  PubMed  Google Scholar 

  90. Sileikyte J, Petronilli V, Zulian A, Dabbeni-Sala F, Tognon G, Nikolov P, Bernardi P, Ricchelli F (2011) Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J Biol Chem 286:1046–1053

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  91. Ricchelli F, Šileikyte J, Bernardi P (2011) Shedding light on the mitochondrial permeability transition. Biochim Biophys Acta 1807:482–490

    Article  CAS  PubMed  Google Scholar 

  92. Lê-Quôc K, Lê-Quôc D (1985) Crucial role of sulfhydryl groups in the mitochondrial inner membrane structure. J Biol Chem 260:7422–7428

    PubMed  Google Scholar 

  93. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y (1998) Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 95:14681–14686

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  94. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL, Prévost MC, Xie Z, Matsuyama S, Reed JC, Kroemer G (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027–2031

    Article  CAS  PubMed  Google Scholar 

  95. Whelan RS, Konstantinidis K, Wei AC, Chen Y, Reyna DE, Jha S, Yang Y, Calvert JW, Lindsten T, Thompson CB, Crow MT, Gavathiotis E, Dorn GW II, O’Rourke B, Kitsis RN (2012) Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci USA 109:6566–6571

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  96. Roy SS, Madesh M, Davies E, Antonsson B, Danial N, Hajnóczky G (2009) Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol Cell 33:377–388

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  97. Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, Xie Z et al (2000) Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329–336

    Article  CAS  PubMed  Google Scholar 

  98. Arbel N, Ben-Hail D, Shoshan-Barmatz V (2012) Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. J Biol Chem 287:23152–23161

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  99. Alavian KN, Li H, Collis L, Bonanni L, Zeng L, Sacchetti S, Lazrove E, Nabili P, Flaherty B, Graham M, Chen Y, Messerli SM, Mariggio MA, Rahner C, McNay E, Shore GC, Smith PJ, Hardwick JM, Jonas EA (2011) Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1 FO ATP synthase. Nat Cell Biol 13:1224–1233

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  100. Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM, Cheng WC, Qi B, Li H, Alavian KN, Dayhoff-Brannigan M, Zou S, Pineda FJ, O’Rourke B, Ko YH, Pedersen PL, Kaczmarek LK, Jonas EA, Hardwick JM (2011) Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol 195:263–276

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  101. Halestrap AP, Pereira GC, Pasdois P (2015) The role of hexokinase in cardioprotection—mechanism and potential for translation. Br J Pharmacol 172:2085–2100

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  102. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652–658

    Article  CAS  PubMed  Google Scholar 

  103. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627–637

    Article  CAS  PubMed  Google Scholar 

  104. Goldstein JC, Muñoz-Pinedo C, Ricci JE, Adams SR, Kelekar A, Schuler M, Tsien RY, Green DR (2005) Cytochrome c is released in a single step during apoptosis. Cell Death Differ 12:453–462

    Article  CAS  PubMed  Google Scholar 

  105. Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD, Green DR (2001) Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 153:319–328

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  106. Polster BM, Kinnally KW, Fiskum G (2001) BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. J Biol Chem 276:37887–37894

    CAS  PubMed  Google Scholar 

  107. von Ahsen O, Renken C, Perkins G, Kluck RM, Bossy-Wetzel E, Newmeyer DD (2000) Preservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. J Cell Biol 150:1027–1036

    Article  Google Scholar 

  108. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189

    Article  CAS  PubMed  Google Scholar 

  109. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131–1141

    Article  CAS  PubMed  Google Scholar 

  110. Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, Nieminen MS, Parvinen M, Voipio-Pulkki LM (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29:380–386

    Article  CAS  PubMed  Google Scholar 

  111. Park M, Shen YT, Gaussin V, Heyndrickx GR, Bartunek J, Resuello RR, Natividad FF, Kitsis RN, Vatner DE, Vatner SF (2009) Apoptosis predominates in nonmyocytes in heart failure. Am J Physiol Heart Circ Physiol 297:H785–H791

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  112. Takemura G, Kanoh M, Minatoguchi S, Fujiwara H (2013) Cardiomyocyte apoptosis in the failing heart—a critical review from definition and classification of cell death. Int J Cardiol 167:2373–2386

    Article  PubMed  Google Scholar 

  113. Dorn GW II (2013) Molecular mechanisms that differentiate apoptosis from programmed necrosis. Toxicol Pathol 41:227–234

    Article  CAS  PubMed  Google Scholar 

  114. Gomes LC, Scorrano L (2013) Mitochondrial morphology in mitophagy and macroautophagy. Biochim Biophys Acta 1833:205–212

    Article  CAS  PubMed  Google Scholar 

  115. Levine B, Sinha S, Kroemer G (2008) Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4:600–606

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  116. Dorn GW II (2010) Mitochondrial pruning by Nix and BNip3: an essential function for cardiac expressed death factors. J Cardiovasc Transl Res 3:374–383

    Article  PubMed Central  PubMed  Google Scholar 

  117. Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, Kirshenbaum LA, Hahn HS, Robbins J, Jones WK, Dorn GW (2007) Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 117:2825–2833

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  118. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, Arnon E, Hayakawa Y, Zimmermann R, Bauer E, Klövekorn WP, Schaper J (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92:715–724

    Article  CAS  PubMed  Google Scholar 

  119. Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM (2001) Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51:304–312

    Article  CAS  PubMed  Google Scholar 

  120. Yamamoto S, Sawada K, Shimomura H, Kawamura K, James TN (2000) On the nature of cell death during remodeling of hypertrophied human myocardium. J Mol Cell Cardiol 32:161–175

    Article  CAS  PubMed  Google Scholar 

  121. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klövekorn WP, Schaper J (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984–991

    Article  PubMed  Google Scholar 

  122. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Yang G, Matsui Y, Sadoshima J, Vatner SF (2005) Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 102:13807–13812

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  123. Miyata S, Takemura G, Kawase Y, Li Y, Okada H, Maruyama R, Ushikoshi H, Esaki M, Kanamori H, Li L, Misao Y, Tezuka A, Toyo-Oka T, Minatoguchi S, Fujiwara T, Fujiwara H (2006) Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol 168:386–397

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  124. Nishida K, Yamaguchi O, Otsu K (2015) Degradation systems in heart failure. J Mol Cell Cardiol 84:212–222

    Article  CAS  PubMed  Google Scholar 

  125. Rothermel BA, Hill JA (2008) Autophagy in load-induced heart disease. Circ Res 103:1363–1369

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  126. Tooze SA, Yoshimori T (2010) The origin of the autophagosomal membrane. Nat Cell Biol 12:831–835

    Article  CAS  PubMed  Google Scholar 

  127. Scherz-Shouval R, Elazar Z (2011) Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36:30–38

    Article  CAS  PubMed  Google Scholar 

  128. Mihaylova MM, Shaw R (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13:1016–1023

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  129. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331:456–461

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  130. Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA (2011) Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS ONE 6:e20975

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  131. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J (2007) Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100:914–922

    Article  CAS  PubMed  Google Scholar 

  132. Biala AK, Kirshenbaum LA (2014) The interplay between cell death signaling pathways in the heart. Trends Cardiovasc Med 24:325–331

    Article  CAS  PubMed  Google Scholar 

  133. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, KarbowskiM YouleRJ (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191:1367–1380

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  134. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27:433–446

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  135. Smirnova E, Griparic L, Shurland DL, van der Bliek AM (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12:2245–2256

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  136. Yoon Y, Krueger EW, Oswald BJ, McNiven MA (2003) The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 23:5409–5420

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  137. MacVicar TD, Lane JD (2014) Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation. J Cell Sci 127:2313–2325

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  138. Kaser M, Kambacheld M, Kisters-Woike B, Langer T (2003) Oma1, a novel membrane bound metallopeptidase in mitochondria with activities overlapping with the m-AAA protease. J Biol Chem 278:46414–46423

    Article  PubMed  CAS  Google Scholar 

  139. McBride H, Soubannier V (2010) Mitochondrial function: OMA1 and OPA1, the grandmasters of mitochondrial health. Curr Biol 20:R274–R276

    Article  CAS  PubMed  Google Scholar 

  140. Shirihai OS, Song M, Dorn GW II (2015) How mitochondrial dynamism orchestrates mitophagy. Circ Res 116:1835–1849

    Article  CAS  PubMed  Google Scholar 

  141. Ikeda Y, Shirakabe A, Brady C, Zablocki D, Ohishi M, Sadoshima J (2015) Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system. J Mol Cell Cardiol 78:116–122

    Article  CAS  PubMed  Google Scholar 

  142. Stotland A, Gottlieb RA (2015) Mitochondrial quality control: easy come, easy go. Biochim Biophys Acta 1853:2802–2811

    Article  CAS  PubMed  Google Scholar 

  143. Neubauer S (2007) The failing heart—an engine out of fuel. N Engl J Med 356:1140–1151

    Article  PubMed  Google Scholar 

  144. Rosca MG, Hoppel CL (2013) Mitochondrial dysfunction in heart failure. Heart Fail Rev 18:607–622

    Article  CAS  PubMed  Google Scholar 

  145. Ventura-Clapier R, Garnier A, Veksler V, Joubert F (2011) Bioenergetics of the failing heart. Biochim Biophys Acta 1813:1360–1372

    Article  CAS  PubMed  Google Scholar 

  146. Marin-Garcia J, Goldenthal MJ (2008) Mitochondrial centrality in heart failure. Heart Fail Rev 13:137–150

    Article  PubMed  Google Scholar 

  147. Ping P, Gustafsson ÅB, Bers DM, Blatter LA, Cai H, Jahangir A, Kelly D, Muoio D, O’Rourke B, Rabinovitch P, Trayanova N, Van Eyk J, Weiss JN, Wong R, Schwartz Longacre L (2015) Harnessing the power of integrated mitochondrial biology and physiology: a special report on the NHLBI mitochondria in heart diseases initiative. Circ Res 117:234–238

    Article  CAS  PubMed  Google Scholar 

  148. Lai L, Leone TC, Keller MP, Martin OJ, Broman AT, Nigro J, Kapoor K, Koves TR, Stevens R, Ilkayeva OR, Vega RB, Attie AD, Muoio DM, Kelly DP (2014) Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circ Heart Fail 7:1022–1031

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  149. Vega RB, Horton JL, Kelly DP (2015) Maintaining ancient organelles: mitochondrial biogenesis and maturation. Circ Res 116:1820–1834

    Article  CAS  PubMed  Google Scholar 

  150. Nickel A, Löffler J, Maack C (2013) Myocardial energetics in heart failure. Basic Res Cardiol 108:358

    Article  PubMed  CAS  Google Scholar 

  151. Carley AN, Taegtmeyer H, Lewandowski ED (2014) Mechanisms linking energy substrate metabolism to the function of the heart. Circ Res 114:717–729

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  152. Taegtmeyer H, Lubrano G (2014) Rethinking cardiac metabolism: metabolic cycles to refuel and rebuild the failing heart. F1000Prime Rep 6:90

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  153. O’Rourke B, Van Eyk JE, Foster DB (2011) Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure. Congest Heart Fail 17:269–282

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  154. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133–3144

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  155. Karamanlidis G, Lee CF, Garcia-Menendez L, Kolwicz SC Jr, Suthammarak W, Gong G, Sedensky MM, Morgan PG, Wang W, Tian R (2013) Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab 18:239–250

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  156. Chipuk JE, Bouchier-Hayes L, Green DR (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13:1396–1402

    Article  CAS  PubMed  Google Scholar 

  157. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G (2012) Non-apoptotic functions of apoptosis-regulatory proteins. EMBO Rep 13:322–330

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  158. Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ, Wang X, Williams RS (2000) Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101:389–399

    Article  CAS  PubMed  Google Scholar 

  159. Brown D, Yu BD, Joza N, Benit P, Meneses J, Firpo M, Rustin P, Penninger JM, Martin GR (2006) Loss of AIF function causes cell death in the mouse embryo, but the temporal progression of patterning is normal. Proc Natl Acad Sci USA 103:9918–9923

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  160. Vahsen N, Candé C, Brière JJ, Bénit P, Joza N, Larochette N, Mastroberardino PG, Pequignot MO, Casares N, Lazar V, Feraud O, Debili N, Wissing S, Engelhardt S, Madeo F, Piacentini M, Penninger JM, Schägger H, Rustin P, Kroemer G (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23:4679–4689

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  161. Joza N, Oudit GY, Brown D, Bénit P, Kassiri Z, Vahsen N, Benoit L, Patel MM, Nowikovsky K, Vassault A, Backx PH, Wada T, Kroemer G, Rustin P, Penninger JM (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy and dilated cardiomyopathy. Mol Cell Biol 25:10261–10272

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  162. Cheung C, Joza N, Steenaart NA, McClellan KA, Neuspiel M, McNamara S, MacLaurin JG, Rippstein P, Park DS, Shore GC, McBride HM, Penninger JM, Slack RS (2006) Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J 25:4061–4073

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  163. Zick M, Rabl R, Reichert AS (2009) Cristae formation-linking ultrastructure and function of mitochondria. Biochim Biophys Acta 1793:5–19

    Article  CAS  PubMed  Google Scholar 

  164. Davies KM, Strauss M, Daum B, Kief JH, Osiewacz HD, Rycovska A, Zickermann V, Kuhlbrandt W (2011) Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc Natl Acad Sci USA 108:14121–14126

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  165. Giraud MF, Paumard P, Soubannier V, Vaillier J, Arselin G, Salin B, Schaeffer J, Brethes D, di Rago JP, Velours J (2002) Is there a relationship between the supramolecular organization of the mitochondrial ATP synthase and formation of cristae? Biochim Biophys Acta 1555:174–182

    Article  CAS  PubMed  Google Scholar 

  166. Paumard P, Vaillier J, Coulary B, Schaeffer J, Soubannier V, Mueller DM, Brethes D, di Rago JP, Velours J (2002) The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J 21:221–230

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  167. Habersetzer J, Larrieu I, Priault M, Salin B, Rossignol R, Brèthes D, Paumard P (2013) Human F1F0 ATP synthase, mitochondrial ultrastructure and OXPHOS impairment: a (super-) complex matter? PLoS ONE 8:e75429

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  168. Williams GS, Boyman L, Lederer WJ (2015) Mitochondrial calcium and the regulation of metabolism in the heart. J Mol Cell Cardiol 78:35–45

    Article  CAS  PubMed  Google Scholar 

  169. Finkel T, Menazza S, Holmström KM, Parks RJ, Liu J, Sun J, Liu J, Pan X, Murphy E (2015) The ins and outs of mitochondrial calcium. Circ Res 116:1810–1819

    Article  CAS  PubMed  Google Scholar 

  170. Long Q, Yang K, Yang Q (2015) Regulation of mitochondrial ATP synthase in cardiac pathophysiology Am J. Cardiovasc Dis 5:19–32

    Google Scholar 

  171. Bernardi P, Rasola A, Forte M, Lippe G (2015) The mitochondrial permeability transition pore: channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology. Physiol Rev 95:1111–1155

    Article  PubMed  Google Scholar 

  172. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233–249

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  173. Wong R, Steenbergen C, Murphy E (2012) Mitochondrial permeability transition pore and calcium handling. Methods Mol Biol 810:235–242

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  174. Morciano G, Giorgi C, Bonora M, Punzetti S, Pavasini R, Wieckowski MR, Campo G, Pinton P (2015) Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. J Mol Cell Cardiol 78:142–153

    Article  CAS  PubMed  Google Scholar 

  175. Weiss JN, Korge P, Honda HM, Ping P (2003) Role of the mitochondrial permeability transition in myocardial disease. Circ Res 93:292–301

    Article  CAS  PubMed  Google Scholar 

  176. De Stefani DD, Raffaello A, Teardo E, Szabò I, Rizzuto R (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476:336–340

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  177. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL, Koteliansky V, Mootha VK (2011) Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476:341–345

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  178. Pan X, Liu J, Nguyen T, Liu C, Sun J, Teng Y, Fergusson MM, Rovira II, Allen M, Springer DA, Aponte AM, Gucek M, Balaban RS, Murphy E, Finkel T (2013) The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol 15:1464–1472

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  179. De Marchi E, Bonora M, Giorgi C, Pinton P (2014) The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux. Cell Calcium 56:1–13

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  180. Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD, Alcocer-Gomez E, Calero CP, Paz MV, Alanis M, de Lavera I, Cotan D, Sanchez-Alcazar JA (2014) Clinical applications of coenzyme Q10. Front Biosci 19:619–633

    Article  CAS  Google Scholar 

  181. Ajith TA, Jayakumar T (2014) Mitochondria-targeted agents: future perspectives of mitochondrial pharmaceutics in cardiovascular diseases. World J Cardiol 6:1091–1099

    Article  PubMed Central  PubMed  Google Scholar 

  182. Yang YK, Wang LP, Chen L, Yao XP, Yang KQ, Gao LG, Zhou XL (2015) Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction. Clin Chim Acta 450:83–89

    Article  CAS  PubMed  Google Scholar 

  183. DiNicolantonio JJ, Bhutani J, McCarty MF, O’Keefe JH (2015) Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart 2(1):e000326

    Article  PubMed Central  PubMed  Google Scholar 

  184. Madmani ME, Yusuf Solaiman A, Tamr Agha K, Madmani Y, Shahrour Y, Essali A, Kadro W (2014) Coenzyme Q10 for heart failure. Cochrane Database Syst Rev 6:CD008684

    PubMed  Google Scholar 

  185. Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP (2014) Q-SYMBIO study investigators. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2:641–649

    Article  PubMed  Google Scholar 

  186. Rizos I (2000) Three-year survival of patients with heart failure caused by dilated cardiomyopathy and l-carnitine administration. Am Heart J 139:S120–S123

    Article  CAS  PubMed  Google Scholar 

  187. Serati AR, Motamedi MR, Emami S, Varedi P, Movahed MR (2010) l-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms. Cardiology 116:178–182

    Article  CAS  PubMed  Google Scholar 

  188. Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, Medicine Society TM (2009) A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 11:414–430

    Article  PubMed Central  PubMed  Google Scholar 

  189. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2:CD007176

    PubMed  Google Scholar 

  190. Cochemé HM, Murphy MP (2010) Can antioxidants be effective therapeutics? Curr Opin Investig Drugs 11:426–431

    PubMed  Google Scholar 

  191. Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656

    Article  CAS  PubMed  Google Scholar 

  192. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276:4588–4596

    Article  CAS  PubMed  Google Scholar 

  193. Smith RA, Porteous CM, Gane AM, Murphy MP (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 100:5407–5412

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  194. Oyewole AO, Birch-Machin MA (2015) Mitochondria-targeted antioxidants. FASEB J 29:4766–4771

    Article  PubMed  Google Scholar 

  195. Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cochemé HM, Murphy MP, Dominiczak AF (2009) Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54:322–328

    Article  CAS  PubMed  Google Scholar 

  196. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA (2005) Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19:1088–1095

    Article  CAS  PubMed  Google Scholar 

  197. Smith RA, Murphy MP (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann NY Acad Sci 1201:96–103

    Article  CAS  PubMed  Google Scholar 

  198. Szeto HH, Birk AV (2014) Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clin Pharmacol Ther 96:672–683

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  199. Javadov S, Karmazyn M, Escobales N (2009) Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 330:670–678

    Article  CAS  PubMed  Google Scholar 

  200. Sileikyte J, Roy S, Porubsky P, Neuenswander B, Wang J, Hedrick M, Pinkerton AB, Salaniwal S, Kung P, Mangravita-Novo A, Smith LH, Bourdette DN, Jackson MR, Aubé J, Chung TDY, Schoenen FJ, Forte MA, Bernardi P (2010) Small molecules targeting the mitochondrial permeability transition. Probe Reports from the NIH Molecular Libraries Program [Internet]. National Center for Biotechnology Information (US), Bethesda

  201. Arakawa S, Nakanomyo I, Kudo-Sakamoto Y, Akazawa H, Komuro I, Shimizu S (2015) Identification of a novel compound that inhibits both mitochondria-mediated necrosis and apoptosis. Biochem Biophys Res Commun 467:1006–1011

    Article  CAS  PubMed  Google Scholar 

  202. Kerr PM, Suleiman MS, Halestrap AP (1999) Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol 276:H496–H502

    CAS  PubMed  Google Scholar 

  203. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP (2000) Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45:360–369

    Article  CAS  PubMed  Google Scholar 

  204. Rajesh KG, Sasaguri S, Suzuki R, Maeda H (2003) Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol 285:H2171–H2178

    Article  CAS  PubMed  Google Scholar 

  205. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM (2007) Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 75:530–535

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  206. Argaud L, Gateau-Roesch O, Chalabreysse L, Gomez L, Loufouat J, Thivolet-Béjui F, Robert D, Ovize M (2004) Preconditioning delays Ca2+-induced mitochondrial permeability transition. Cardiovasc Res 61:115–122

    Article  CAS  PubMed  Google Scholar 

  207. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM (2002) Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial pre-conditioning? Cardiovasc Res 55:534–543

    Article  CAS  PubMed  Google Scholar 

  208. Dongworth RK, Hall AR, Burke N, Hausenloy DJ (2014) Targeting mitochondria for cardioprotection: examining the benefit for patients. Future Cardiol 10:255–272

    Article  CAS  PubMed  Google Scholar 

  209. Mio Y, Uezono S, Kitahata H (2014) Anesthetic cardioprotection in relation to mitochondria: basic science. Curr Pharm Des 20:5673–5680

    Article  CAS  PubMed  Google Scholar 

  210. Coetzee WA (2013) Multiplicity of effectors of the cardioprotective agent, diazoxide. Pharmacol Ther 140:167–175

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  211. Akao M, Teshima Y, Marbán E (2002) Antiapoptotic effect of nicorandil mediated by mitochondrial ATP-sensitive potassium channels in cultured cardiac myocytes. J Am Coll Cardiol 21:803–810

    Article  Google Scholar 

  212. IONA Study Group (2002) Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359:1269–1275

    Article  Google Scholar 

  213. Zhao F, Chaugai S, Chen P, Wang Y, Wang DW (2014) Effect of nicorandil in patients with heart failure: a systematic review and meta-analysis. Cardiovasc Ther 32:283–296

    Article  CAS  PubMed  Google Scholar 

  214. Kasama S, Toyama T, Iwasaki T, Sumino H, Kumakura H, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M (2014) Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching. Eur J Nucl Med Mol Imaging 41:144–154

    Article  CAS  PubMed  Google Scholar 

  215. Ishihara S, Koga T, Kaseda S, Nyuta E, Haga Y, Fujishima S, Ishitsuka T, Sadoshima S (2012) Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome. Circ J 76:1169–1176

    Article  CAS  PubMed  Google Scholar 

  216. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K et al (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22:58–73

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Christopher’s Hospital for Children, Drexel University College of Medicine, Philadelphia, PA, 19134, USA

    Michael J. Goldenthal

Authors
  1. Michael J. Goldenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Goldenthal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goldenthal, M.J. Mitochondrial involvement in myocyte death and heart failure. Heart Fail Rev 21, 137–155 (2016). https://doi.org/10.1007/s10741-016-9531-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-016-9531-1

Keywords

Search

Navigation